Page 3 - Otonomy Inc News Today

Mr. Trump revved up supporters Saturday at the Conservative Political Action Conference outside Washington-an event Mr. DeSantis skipped-while the governor appeared before Republican groups in Texas and gave a speech Sunday afternoon at the Ronald Reag... | 06:20am

/PRNewswire/ -- According to Technavio, the global ear infection treatment market size is estimated to grow by USD 3.67 billion from 2021 to 2026. The market...

More than half of patients treated with cisplatin-based chemotherapy develop hearing loss or tinnitus, which can be devastating, say researchers who urge that all patients should be tested routinely.

--

NEW YORK, Dec. 28, 2022 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock, unit, and warrant of Tuscan...

SAN DIEGO, Dec. 22, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC) today announced that it received a letter from the Listing Qualifications Staff...

Gainers Core Scientific, Inc. (NASDAQ:CORZ) shares rose 77.7% to $0.0906 in pre-market trading. Core Scientific shares dipped 75% on Wednes...

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Item 2.02 Results of Operations and Financial Condition. Otonomy, Inc. reports that its estimated cash balance including cash and cash equivalents totaled $40.1 million as of September 30, 2022. The... | October 14, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Arcutis Psoriasis Treatment Scores FDA App...